1-247574351-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145278.5(GCSAML):āc.377A>Gā(p.Glu126Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000256 in 1,613,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145278.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GCSAML | NM_145278.5 | c.377A>G | p.Glu126Gly | missense_variant | 5/5 | ENST00000366488.5 | |
LOC102724446 | XR_426948.4 | n.226-8400T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GCSAML | ENST00000366488.5 | c.377A>G | p.Glu126Gly | missense_variant | 5/5 | 1 | NM_145278.5 | P1 | |
ENST00000435333.5 | n.226-8400T>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000387 AC: 97AN: 250836Hom.: 0 AF XY: 0.000347 AC XY: 47AN XY: 135546
GnomAD4 exome AF: 0.000268 AC: 392AN: 1461774Hom.: 0 Cov.: 31 AF XY: 0.000264 AC XY: 192AN XY: 727186
GnomAD4 genome AF: 0.000138 AC: 21AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.377A>G (p.E126G) alteration is located in exon 5 (coding exon 5) of the GCSAML gene. This alteration results from a A to G substitution at nucleotide position 377, causing the glutamic acid (E) at amino acid position 126 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at